跳转至内容
Merck
所有图片(2)

文件

A7791

Sigma-Aldrich

N-乙酰-D-乳糖胺

≥98% (TLC)

别名:

β-D-Gal-(1→4)-D-GlcNAc, 2-乙酰氨基-2-脱氧-4-O-β-D-半乳吡喃糖基-D-吡喃葡萄糖, LN, N-乙酰基-4-O-(β-D-半乳吡喃糖基）-D葡糖胺

登录查看公司和协议定价
所有图片(2)

About This Item

经验公式（希尔记法）:
C14H25NO11
CAS号:
32181-59-2
分子量:
383.35
Beilstein:
96808
MDL號碼:
MFCD00063785
分類程式碼代碼:
12352201
PubChem物質ID:
24891280
NACRES:
NA.25

化驗

≥98% (TLC)

形狀

powder

光學活性

[α]25/D 27.5 to 33.5 °, c = 0.5% (w/v) in water

技術

thin layer chromatography (TLC): suitable

雜質

≤8% water

顏色

white

mp

170 -185  °C ((338 - 365 °F ))

溶解度

water: 50 mg/mL, clear to very slightly hazy, colorless to faintly yellow

儲存溫度

−20°C

SMILES 字串

CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O

InChI

1S/C14H25NO11/c1-4(18)15-7-9(20)12(6(3-17)24-13(7)23)26-14-11(22)10(21)8(19)5(2-16)25-14/h5-14,16-17,19-23H,2-3H2,1H3,(H,15,18)/t5-,6-,7-,8+,9-,10+,11-,12-,13?,14+/m1/s1

InChI 密鑰

KFEUJDWYNGMDBV-RPHKZZMBSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

應用

N-乙酰基-D-乳糖胺可在糖结合分子（如半乳糖凝集素）的鉴定和分化中用作特异性凝集素靶分子。N-乙酰基-D-乳糖胺可用于半乳糖苷酶、岩藻糖基转移酶、唾液酸转移酶和凝集素抑制的研究中。
可用于半乳糖苷酶、岩藻糖基转移酶、唾液酸转移酶和凝集素抑制的研究。

準備報告

合成

其他說明

为了全面了解我们针对客户研究提供的各种双糖产品，建议您访问我们的碳水化合物分类页面。

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Fumi Kato et al.
Breast cancer (Tokyo, Japan), 26(5), 628-636 (2019-04-03)
We investigated the usefulness of the minimum ADC value of primary breast lesions for predicting axillary lymph node (LN) status in luminal A-like breast cancers with clinically negative nodes in comparison with the mean ADC. Forty-four luminal A-like breast cancers
Lital Sever et al.
Proceedings of the National Academy of Sciences of the United States of America, 116(33), 16489-16496 (2019-07-28)
SLAMF9 belongs to the conserved lymphocytic activation molecule family (SLAMF). Unlike other SLAMs, which have been extensively studied, the role of SLAMF9 in the immune system remained mostly unexplored. By generating CRISPR/Cas9 SLAMF9 knockout mice, we analyzed the role of
Frank Liang et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 25(12), 2635-2647 (2017-09-30)
mRNA vaccines are rapidly emerging as a powerful platform for infectious diseases because they are well tolerated, immunogenic, and scalable and are built on precise but adaptable antigen design. We show that two immunizations of modified non-replicating mRNA encoding influenza
Fumiko Suenaga et al.
Journal of immunology (Baltimore, Md. : 1950), 194(1), 398-406 (2014-11-26)
Graft-versus-host disease (GVHD) is a major risk factor for prolonged humoral immunodeficiency and vaccine unresponsiveness after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the underlying mechanisms for this immunodeficiency are poorly understood. In this article, we describe previously overlooked impacts
Meghan Rothenberger et al.
Journal of acquired immune deficiency syndromes (1999), 81(3), 355-360 (2019-06-14)
HIV is produced in lymphoid tissues (LT) and stored on the follicular dendritic cell network in LT. When antiretroviral therapy is started, plasma viremia decays in 2 phases; the first within days of starting therapy and the second over weeks.
查看所有相关文献

商品

O-连接糖蛋白回顾

O-连接糖蛋白通常是分子量>200kDa的大蛋白。糖基化通常发生在高密度簇上，并可占总量的50-80%。

Review of O-Linked Glycoproteins

O-Linked glycoproteins are usually large proteins with a molecular mass of >200 kDa. Glycosylation generally occurs in high-density clusters and may represent as much as 50-80% of the overall mass.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门